CONMED Corporation (CNMD): Price and Financial Metrics

CONMED Corporation (CNMD): $76.41

1.03 (-1.33%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

CNMD Price/Volume Stats

Current price $76.41 52-week high $138.47
Prev. close $77.44 52-week low $75.16
Day low $75.16 Volume 825,700
Day high $77.83 Avg. volume 584,447
50-day MA $89.84 Dividend yield 1.02%
200-day MA $106.72 Market Cap 2.35B

CNMD Stock Price Chart Interactive Chart >

CNMD POWR Grades

  • Growth is the dimension where CNMD ranks best; there it ranks ahead of 96.76% of US stocks.
  • CNMD's strongest trending metric is Growth; it's been moving up over the last 26 weeks.
  • CNMD ranks lowest in Sentiment; there it ranks in the 20th percentile.

CNMD Stock Summary

  • With a price/earnings ratio of 57.48, CONMED CORP P/E ratio is greater than that of about 88.1% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for CONMED CORP is higher than 94.36% of stocks in our set with a positive cash flow.
  • Over the past twelve months, CNMD has reported earnings growth of -2,001.84%, putting it ahead of merely 0.79% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CONMED CORP are VSAT, DGICA, MNTX, JVA, and CTHR.
  • CNMD's SEC filings can be seen here. And to visit CONMED CORP's official web site, go to www.conmed.com.

CNMD Valuation Summary

  • In comparison to the median Healthcare stock, CNMD's price/earnings ratio is 99.31% higher, now standing at 58.1.
  • CNMD's EV/EBIT ratio has moved up 48.5 over the prior 243 months.

Below are key valuation metrics over time for CNMD.

Stock Date P/S P/B P/E EV/EBIT
CNMD 2023-12-29 2.9 4.2 58.1 62.8
CNMD 2023-12-28 2.9 4.3 59.3 63.8
CNMD 2023-12-27 3.0 4.3 59.5 64.0
CNMD 2023-12-26 3.0 4.4 60.3 64.6
CNMD 2023-12-22 3.0 4.4 59.9 64.2
CNMD 2023-12-21 2.9 4.3 59.0 63.5

CNMD Growth Metrics

    Its 5 year cash and equivalents growth rate is now at -29.86%.
  • Its 4 year cash and equivalents growth rate is now at -29.86%.
  • Its 2 year revenue growth rate is now at 7.32%.
Over the past 15 months, CNMD's revenue has gone up $90,074,000.

The table below shows CNMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,068.575 78.748 -82.722
2022-06-30 1,042.314 74.217 -113.924
2022-03-31 1,020.285 89.754 67.657
2021-12-31 1,010.635 111.77 62.542
2021-09-30 989.493 98.13 62.238
2021-06-30 978.501 111.894 54.14

CNMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CNMD has a Quality Grade of C, ranking ahead of 54.31% of graded US stocks.
  • CNMD's asset turnover comes in at 0.564 -- ranking 77th of 186 Medical Equipment stocks.
  • OSUR, MMSI, and BSX are the stocks whose asset turnover ratios are most correlated with CNMD.

The table below shows CNMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.564 0.554 0.083
2021-06-30 0.559 0.551 0.086
2021-03-31 0.506 0.533 0.045
2020-12-31 0.495 0.534 0.038
2020-09-30 0.500 0.534 0.041
2020-06-30 0.497 0.532 0.033

CONMED Corporation (CNMD) Company Bio


CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company was founded in 1970 and is based in Utica, New York.


CNMD Latest News Stream


Event/Time News Detail
Loading, please wait...

CNMD Latest Social Stream


Loading social stream, please wait...

View Full CNMD Social Stream

Latest CNMD News From Around the Web

Below are the latest news stories about CONMED CORP that investors may wish to consider to help them evaluate CNMD as an investment opportunity.

CONMED Corporation to Present at the J.P. Morgan Healthcare Conference

LARGO, Fla., December 21, 2023--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan Healthcare Conference at 2:15 p.m. PT (5:15 p.m. ET) on Monday, January 8, 2024 in San Francisco, CA.

Yahoo | December 21, 2023

CONMED Corporation's (NYSE:CNMD) P/S Is On The Mark

It's not a stretch to say that CONMED Corporation's ( NYSE:CNMD ) price-to-sales (or "P/S") ratio of 3x right now seems...

Yahoo | December 18, 2023

Here's Why You Should Retain CONMED (CNMD) Stock for Now

CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.

Yahoo | December 15, 2023

Align Technology (ALGN) Moves 11.1% Higher: Will This Strength Last?

Align Technology (ALGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Yahoo | December 15, 2023

Insider Sell Alert: Conmed Corp's President AS and AET Peters Stanley W III Offloads Shares

In the realm of stock market movements, insider trading activity is often a significant indicator that investors keep an eye on to gauge the confidence levels of a company's executives in their own firm's prospects.

Yahoo | December 7, 2023

Read More 'CNMD' Stories Here

CNMD Price Returns

1-mo -5.47%
3-mo -29.35%
6-mo -24.35%
1-year -17.50%
3-year -37.78%
5-year -3.08%
YTD -30.06%
2023 24.45%
2022 -36.98%
2021 27.35%
2020 1.16%
2019 75.71%

CNMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CNMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!